Stay updated on REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial page.

Latest updates to the REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe standard funding/operating-status notice has been removed from the page.SummaryDifference0.2%

- Check35 days agoChange DetectedLevomecor Inc. was added as the sponsor and Relmada Therapeutics, Inc. was removed; the record now shows 'Last Update Posted (Estimated)'.SummaryDifference0.3%

- Check49 days agoChange DetectedNo substantive changes detected between the two page states; only backend QC updates to study record dates (First Submitted 2021-04-19, Last Update 2025-01-17). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedUpdated to v3.2.0 with a government-status notice; removed v3.1.0.SummaryDifference4%

- Check78 days agoChange DetectedCore content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.SummaryDifference0.5%

Stay in the know with updates to REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial page.